Wall Street Experts
ver. ZuMIgo(08/25)
China Shineway Pharmaceutical Group Limited
Rachunek Zysków i Strat
Przychody TTM (mln): 8 467
EBIT TTM (mln): 1 684
index |
0 |
1 |
2 |
3 |
4 |
5 |
6 |
7 |
8 |
9 |
10 |
11 |
12 |
13 |
14 |
15 |
16 |
17 |
18 |
19 |
20 |
21 |
Rok finansowy |
2003 |
2004 |
2005 |
2006 |
2007 |
2008 |
2009 |
2010 |
2011 |
2012 |
2013 |
2014 |
2015 |
2016 |
2017 |
2018 |
2019 |
2020 |
2021 |
2022 |
2023 |
2024 |
Przychód (mln) |
604 |
704 |
831 |
841 |
1,013 |
1,275 |
1,633 |
2,038 |
1,985 |
2,132 |
2,187 |
2,229 |
2,055 |
1,993 |
1,920 |
2,570 |
2,706 |
2,656 |
3,224 |
3,951 |
4,517 |
3,778 |
Przychód Δ r/r |
0.0% |
16.5% |
18.2% |
1.2% |
20.4% |
25.9% |
28.1% |
24.8% |
-2.6% |
7.4% |
2.6% |
1.9% |
-7.8% |
-3.0% |
-3.7% |
33.9% |
5.3% |
-1.9% |
21.4% |
22.6% |
14.3% |
-16.4% |
Marża brutto |
47.9% |
64.2% |
66.9% |
70.4% |
72.9% |
71.7% |
72.1% |
70.4% |
65.6% |
65.3% |
67.4% |
66.3% |
66.2% |
64.5% |
66.0% |
73.0% |
73.2% |
74.9% |
74.8% |
74.4% |
75.1% |
75.0% |
EBIT (mln) |
184 |
280 |
324 |
341 |
369 |
444 |
838 |
944 |
950 |
675 |
690 |
701 |
614 |
565 |
408 |
494 |
476 |
422 |
534 |
714 |
976 |
843 |
EBIT Δ r/r |
0.0% |
51.9% |
15.8% |
5.1% |
8.2% |
20.3% |
88.9% |
12.6% |
0.6% |
-28.9% |
2.2% |
1.5% |
-12.3% |
-8.1% |
-27.7% |
21.1% |
-3.6% |
-11.4% |
26.5% |
33.5% |
36.7% |
-13.6% |
EBIT (%) |
30.5% |
39.8% |
39.0% |
40.5% |
36.4% |
34.8% |
51.3% |
46.3% |
47.8% |
31.7% |
31.5% |
31.4% |
29.9% |
28.3% |
21.3% |
19.2% |
17.6% |
15.9% |
16.6% |
18.1% |
21.6% |
22.3% |
Koszty finansowe (mln) |
40 |
8 |
-18 |
-46 |
-207 |
-33 |
-46 |
-48 |
-0 |
-124 |
3 |
17 |
0 |
0 |
0 |
0 |
3 |
17 |
1 |
1 |
3 |
6 |
EBITDA (mln) |
206 |
302 |
350 |
370 |
401 |
480 |
883 |
997 |
1,015 |
757 |
788 |
845 |
777 |
756 |
603 |
692 |
673 |
622 |
705 |
888 |
1,420 |
1,002 |
EBITDA(%) |
34.1% |
43.0% |
42.1% |
44.0% |
39.6% |
37.6% |
54.1% |
48.9% |
51.2% |
35.5% |
36.0% |
37.9% |
37.8% |
37.9% |
31.4% |
26.9% |
24.9% |
23.4% |
21.9% |
22.5% |
31.4% |
26.5% |
Podatek (mln) |
-7 |
11 |
5 |
54 |
85 |
78 |
117 |
170 |
194 |
152 |
176 |
159 |
139 |
106 |
136 |
163 |
140 |
100 |
163 |
194 |
271 |
306 |
Zysk Netto (mln) |
151 |
261 |
337 |
333 |
491 |
398 |
767 |
822 |
756 |
648 |
684 |
705 |
658 |
589 |
452 |
506 |
503 |
295 |
557 |
723 |
970 |
840 |
Zysk netto Δ r/r |
0.0% |
72.3% |
29.2% |
-1.2% |
47.3% |
-18.8% |
92.7% |
7.1% |
-8.1% |
-14.3% |
5.5% |
3.1% |
-6.7% |
-10.4% |
-23.4% |
12.0% |
-0.5% |
-41.4% |
88.7% |
29.8% |
34.1% |
-13.4% |
Zysk netto (%) |
25.1% |
37.1% |
40.5% |
39.6% |
48.4% |
31.2% |
47.0% |
40.3% |
38.1% |
30.4% |
31.3% |
31.6% |
32.0% |
29.6% |
23.5% |
19.7% |
18.6% |
11.1% |
17.3% |
18.3% |
21.5% |
22.2% |
EPS |
0.25 |
0.42 |
0.4 |
0.4 |
0.59 |
0.48 |
0.93 |
0.99 |
0.91 |
0.78 |
0.83 |
0.85 |
0.8 |
0.71 |
0.55 |
0.62 |
0.64 |
0.39 |
0.74 |
0.96 |
1.28 |
1.11 |
EPS (rozwodnione) |
0.25 |
0.42 |
0.4 |
0.4 |
0.59 |
0.48 |
0.93 |
0.99 |
0.91 |
0.78 |
0.83 |
0.85 |
0.8 |
0.71 |
0.55 |
0.62 |
0.64 |
0.39 |
0.74 |
0.96 |
1.28 |
1.11 |
Ilośc akcji (mln) |
605 |
621 |
829 |
827 |
827 |
827 |
827 |
827 |
827 |
827 |
827 |
827 |
827 |
827 |
827 |
816 |
781 |
756 |
755 |
755 |
757 |
757 |
Ważona ilośc akcji (mln) |
605 |
621 |
829 |
827 |
827 |
827 |
827 |
827 |
827 |
827 |
827 |
827 |
827 |
827 |
827 |
818 |
781 |
757 |
755 |
755 |
755 |
755 |
Waluta |
CNY |
CNY |
CNY |
CNY |
CNY |
CNY |
CNY |
CNY |
CNY |
CNY |
CNY |
CNY |
CNY |
CNY |
CNY |
CNY |
CNY |
CNY |
CNY |
CNY |
CNY |
CNY |